Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
11.71(c) 11.68(c) 11.73(c) 11.85(c) 11.815 Last
456 446 348 846 487 378 321 129 40 995 Volume
-0.09% -0.26% +0.43% +1.02% -0.30% Change
More quotes
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies.Prostones are naturally occurring fatty acid metabolites with unique physiological... 
Surperformance© rating of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 120 M
EBIT 2014 33,9 M
Net income 2014 10,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 129 M
EBIT 2015 38,5 M
Net income 2015 23,9 M
Finance 2015 32,3 M
Yield 2015 -
PER 2014 55,76
PER 2015 23,61
EV / Sales 2014 4,40x
EV / Sales 2015 3,81x
Capitalization 526 M
More Financials
Latest news on SUCAMPO PHARMACEUTICALS, I
1d ago SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 26th Annu..
11/12 SUCAMPO PHARMACEUTICALS : Files Patent Infringement Lawsuit Against Dr. Reddy's
11/12 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure (form 8-K)
11/11 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the Stifel 20..
11/07 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
11/06 SUCAMPO PHARMACEUTICALS : posts 3Q profit
11/06 SUCAMPO PHARMACEUTICALS : Results of Operations and Financial Condition, Regulat..
11/06 SUCAMPO PHARMACEUTICALS : Announces Third Quarter 2014 Financial Results
11/05 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Cre..
11/04DJReckitt Benckiser Pharmaceuticals Names Cary Claiborne Financial Chief
10/24 SUCAMPO PHARMACEUTICALS : Announces Third Quarter 2014 Earnings Call
10/23 SUCAMPO PHARMACEUTICALS : Solidifies Leadership Team With Additions of CSO and H..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF